Access cutting-edge influenza treatment through this clinical trial at a research site in Mishawaka. Study-provided care at no cost to qualified participants.
Access influenza specialists in Mishawaka at no cost
This study follows strict safety protocols and ethical guidelines
All study-related influenza treatment provided free
This study consists of two parts: Part A Surveillance and Part B Transmission. The main purpose of Part A is to evaluate the prevalence of pre-dose and treatment-emergent amino acid substitutions in pediatric participants' susceptibility \<12 years with influenza treated with baloxavir marboxil. Part B will include a subset of Part A participants who have household contacts (HHCs) recruited to the study. Part B will evaluate the incidence of onward influenza transmission from pediatric index p
Sponsor: Hoffmann-La Roche
Check if you qualify for this influenza clinical trial in Mishawaka, IN
If you're searching for influenza treatment options in Mishawaka, IN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Mishawaka research site is actively enrolling participants for this clinical trial. You'll receive care from experienced influenza specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.